1-[7-(Chlorodifluoromethyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-4-phenylpiperazine

Catalog No. :
ACSHGM362
CAS No. :
691873-03-7
Molecular Formula :
C17H17ClF2N6
Molecular Weight :
378.81

IUPAC Name:7-(chlorodifluoromethyl)-5-methyl-2-(4-phenylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine

1-[7-(Chlorodifluoromethyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-4-phenylpiperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[7-(Chlorodifluoromethyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-4-phenylpiperazine
IUPAC Name7-(chlorodifluoromethyl)-5-methyl-2-(4-phenylpiperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine
Molecular FormulaC17H17ClF2N6
Molecular Weight378.81
SMILESCC1=NC2=NC(N3CCN(C4=CC=CC=C4)CC3)=NN2C(C(F)(Cl)F)=C1
InChI KeyRFJUPNKXQPIRGU-UHFFFAOYSA-N
Synonym7-[CHLORO(DIFLUORO)METHYL]-5-METHYL-2-(4-PHENYLPIPERAZINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE;1-[7-(chlorodifluoromethyl)-5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]-4-phenylpiperazine;[1,2,4]Triazolo[1,5-a]pyrimidine, 7-(chlorodifluoromethyl)-5-methyl-2-(4-phenyl-1-piperazinyl)-
CAS No.691873-03-7

Synthetic Route by SureRoute

1. ACSHGM362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCPZB630 route compound structure diagram
    ACCPZB630591-50-4 In Stock
  4. Then
  5. ACSHGM362 route product structure diagram
    ACSHGM362691873-03-7
Inquiry

2. ACSHGM362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYFBQ972 route compound structure diagram
    ACYFBQ972553-27-5 In Stock
  4. Then
  5. ACSHGM362 route product structure diagram
    ACSHGM362691873-03-7
Inquiry

Comments (0)